Alto Neuroscience, Inc. (NYSE: ANRO) reported Q2 EPS of ($0.65), $0.05 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.